Italia Markets open in 6 hrs 16 mins

Siegfried Holding AG (0QQO.L)

LSE - LSE Prezzo differito. Valuta in CHF.
Aggiungi a watchlist
876,82-1,18 (-0,13%)
Alla chiusura: 06:45PM BST

Siegfried Holding AG

Untere Bruehlstrasse 4
Zofingen 4800
Switzerland
41 62 746 1111
https://www.siegfried.ch

Settore/i
Settore
Impiegati a tempo pieno3.819

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Dr. Wolfgang Wienand Ph.D.Chief Executive Officer2,23MN/D1972
Dr. Reto Suter Ph.D.Chief Financial OfficerN/DN/D1971
Dr. Jurgen Roos Ph.D.Chief Scientific OfficerN/DN/D1968
Dr. Luca Dalla TorreGeneral Counsel & SecretaryN/DN/DN/D
Mr. Peter StierliHead of Corporate CommunicationsN/DN/DN/D
Ms. Irene WosgienChief Human Resources OfficerN/DN/D1973
Ms. Marianne SpaneChief Business Officer of Drug Substances & Drug ProductsN/DN/D1962
Mr. Enno Schweinberger Ph.D.Head Global Quality Management DS - ZofingenN/DN/DN/D
Daniel NieperChief Strategy OfficerN/DN/DN/D
Mr. Marcel ImwinkelriedChief Operating Officer Drug ProductsN/DN/D1967
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in CHF.

Descrizione

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products. In addition, it provides APIs and controlled substances focusing on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition; exclusive synthesis services comprising process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing; and viral vector manufacturing solutions. Further, the company licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for products. Siegfried Holding AG was founded in 1873 and is headquartered in Zofingen, Switzerland.

Governance aziendale

L'ISS Governance QualityScore di Siegfried Holding AG al 1 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 6; diritti degli azionisti: 1; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.